• Adel Z. El-sonbati Chemistry Department, Faculty of Science, Damietta University, Damietta 34517, Egypt
  • Rizk A. El-baz Chemistry Department, Faculty of Medicine, Mansoura University, Egypt
  • Entsar A. Saad Chemistry Department, Faculty of Science, Damietta University, Damietta 34517, Egypt
  • Abeer S. El-zekred Chemistry Department, Faculty of Science, Damietta University, Damietta 34517, Egypt


Vascular endothelial growth factor, Polymorphisms, Pre-eclampsia


Vascular endothelial growth factor gene plays a crucial role in physiological vasculogenesis and vascular permeability and has been implicated in the pathogenesis of pre-eclampsia (PE). VEGF's normal function is to create new blood vessels during embryonic development, new blood vessels after injury, muscle following exercise, and new vessels (collateral circulation) to bypass blocked vessels. This study carried on 170 pregnant women. Out of them, 100 cases with PE. Their mean age ± SD was 25.28 ± 4.59 years. Seventy nine (79%) cases had mild PE and 21 (21%) cases had severe PE. The other 70 subjects were clinically healthy pregnant women with complete successful pregnancy and no PE. VEGF C 405 G and C 2578 A polymorphisms were studied using PCR and RFLP. We found that PE among Egyptian women was strongly associated with pre-eclamptic mutations related to VEGF C 405 G and C 2578 A gene polymorphisms. There were statistically significant low frequencies of wild homozygous genotype CC and high frequencies of heterozygous mutant genotypes CG & CA and homozygous mutant genotypes GG & AA in PE cases compared to controls. The frequency of cases carrying the homozygous mutant genotype GG was higher among severe pre-eclamptic cases compared to mild pre-eclamptic cases. In addition, there were statistically significant high frequencies in PE cases compared to controls of mutant G and mutant A alleles.


Download data is not yet available.


Walker JJ. Pre-eclampsia. Lancet 2000;356(9237):1260-5.

Escudero C, Celis T, Saez S, San Martin FJ, Valenzuela C, Aguayo P, et al. Increased placental angiogenesis in late and early onset PE is associated with differential activation of vascular endothelial growth factor receptor 2. Placenta 2014;35:207-15.

Sibai BM. Intergenerational factors. A missing link for preeclampsia, fetal growth restriction, and cardiovascular disease? Hypertension 2008;51(4):993-4.

Abu Samra K. The eye and visual system in the preeclampsia/eclampsia syndrome: what to expect? Saudi J Ophthalmol 2013;27:51–3.

Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001;344(12):867-72.

Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993;4(1):59-61.

Arngrintsson R, Geirsson RT, Cooke A, Connqr M, Bjornsson S, Walker JJ. Renin gene restriction fragment length polymorphisms do not show linkage with preeclampsia and eclampsia. Acta Obstet Gynecol Scand 1994;73(1):10-3.

Arngrimsson R, Hayward C, Nadaud S, Baldursdottir A, Walker JJ, Liston WA, et al. Evidence for a familial pregnancy. Induced hypertension locus in the eNOS-gene region. Am J Hum Genet 1997;61(2):354-62.

Guo G, Wilton AN, Fu Y, Qiu H, Brennecke SP, Cooper DW. Angiotensinogen gene variation in a population case-control study of preeclampsia/eclampsia in Australians and Chinese. Electrophoresis 1997;18(9):1646-9.

Lacluneijer AM, Arngrbnsson R, Bastiaans EJ, Pals G, Ten Kate LP, de Vries JL, et al. Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels and vitamin status in women with a history of preeclampsia. Am J Obstet Gynecol 2001;184(3):394-402.

Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161(5):1200-4•

Roberts JM. Preeclampsia: what we know and what we do not know. Semin Perihatol 2000;24(1):24-8.

Moran P, Baylis PH, Lindheimer MD, Davison JM. Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol 2003;14:648-52.

Rolfo A, Many A, Racano A, Tal R, Tagliaferro A, Ietta F. Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLOS One 2010;5(10):13288.

Gill JS, Salafia CM, Grebenkov D, Vvedensky DD. Modeling oxygen transport in human placental terminal villi. J Theor Biol 2011;291:33-41.

Bányász I, Szabo S, Bokodi G, Vannay A, Vasarhelyi B, Szabo A, et al. Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia. Mol Hum Reprod 2006;12:233–6.

Nejatizadeh A, Stobdan T, Malhotra N, Pasha MA. The genetic aspects of pre-eclampsia; achievements and limitations. Biochem Genet 2008;46:451-79.

Papazoglou D, Galazios G, koukourakis ML, Panagopoulos I, Kontomanolis EN, Papatheodorou K, et al. Vascular endothelial growth factor gene polymorphisms and preeclampsia. Mol Hum Reprod 2004;10(5):321-4.

Sandrim VC, Palei AC, Cavalli RC, Araujo FM, Ramos ES, et al. Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod 2009;15(2):115-20.

Garza-veloz L, Castruita-Dela Rosa C, Cortex-Flores R, Martinez-Gaytan V, Rivera-Mufioz JE, Garcia-Mayorga EA, et al. No association between polymorphisms /haplotypes of the vascular endothelial growth factor gene and preeclampsia. BMC Pregnancy Childbirth 2011;11-35.

Shim JY, Jun JK, Jung BK, Kim SH, Won HS, Lee PR, et al. Vascular endothelial growth factor gene +936 CIT polymorphisms is associated with preeclampsia in korean women. Am J Obstet Gynecol 2007;197:271-1.

Roberts JM. Preeclampsia: new approaches but the same old problems. Am J Obstet Gynecol 2008;199:443-4.

Watson CJ, Wepp NJ, Bottomley MJ, Brenchley PE. Identification of Polymorphisms within the vascular endothelial growth factor VEGF protein production. Cytokine 2000;1232:12-1235.



How to Cite

El-sonbati, A. Z., R. A. El-baz, E. A. Saad, and A. S. El-zekred. “VASCULAR ENDOTHELIAL GROWTH FACTOR VEGF G/C 405 AND C/A 2578 GENE POLYMORPHISMS IN CASES WITH PRE-ECLAMPSIA”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 10, Oct. 2014, pp. 281-4,



Original Article(s)